XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 215,924 $ 199,252
Restricted cash 525 525
Short-term investments 90,739 121,407
Accounts receivable, net 123,691 133,563
Inventory 239,408 258,616
Prepaid and other current assets 31,552 11,618
Total current assets 701,839 724,981
Property, plant and equipment, net 49 114
Long-term inventory 71,294 77,615
Operating lease right-of-use asset 7,540 8,310
Other long-term assets 1,287 1,360
Intangible asset, net 17,846 19,304
TOTAL ASSETS 799,855 831,684
Current Liabilities:    
Accounts payable 54,383 52,762
Accrued expenses and other current liabilities 176,159 204,174
Current deferred revenue   2,341
Total current liabilities 230,542 259,277
Long-Term Liabilities:    
Long-term deferred revenue   2,509
Long-term operating lease liability 8,099 8,737
Other long-term liabilities 9,335 9,064
Total liabilities 247,976 279,587
Commitments and contingencies (Note 5)
Stockholders’ Equity:    
Common stock, GBP 0.50 par, unlimited authorized; 421,751,350 shares issued, 411,113,770 shares outstanding as of June 30,2024; 418,141,295 shares issued, 408,824,093 shares outstanding as of December 31, 2023 305,046 302,756
Additional paid-in capital 1,906,903 1,899,456
Treasury stock; 10,637,580 shares as of June 30, 2024; 9,317,202 shares as of December 31, 2023 (65,276) (63,752)
Accumulated deficit (1,594,794) (1,586,363)
Total stockholders’ equity 551,879 552,097
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 799,855 $ 831,684